Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2006-5-15
pubmed:abstractText
Acquired drug resistance or gradual drug failure has been described with most disease modifying antirheumatic drugs (DMARDs) and is also starting to be recognised with anti-tumour necrosis factor (anti-TNF) agents.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-10852987, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-10955408, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-10986302, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-11096165, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-11096166, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-11759233, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-12115174, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-12176803, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-12465146, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-12480663, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-12528101, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-12584368, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-12614731, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-12671888, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-12806611, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-12913927, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-14673982, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-14719194, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-14722201, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-14722202, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-14872477, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-15001324, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-15020338, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-15033655, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-15127338, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-15170907, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-15290732, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-15598707, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-15708884, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-15769924, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-16385495, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-16699049, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-1976811, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-2910056, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-7362664, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-7779122, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-7818570, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-8546736, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339288-8591645
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0003-4967
pubmed:author
pubmed:issnType
Print
pubmed:volume
65
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
746-52
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:16339288-Analysis of Variance, pubmed-meshheading:16339288-Antibodies, Monoclonal, pubmed-meshheading:16339288-Antibodies, Monoclonal, Humanized, pubmed-meshheading:16339288-Antirheumatic Agents, pubmed-meshheading:16339288-Data Collection, pubmed-meshheading:16339288-Disease Progression, pubmed-meshheading:16339288-Dose-Response Relationship, Drug, pubmed-meshheading:16339288-Drug Administration Schedule, pubmed-meshheading:16339288-Drug Resistance, pubmed-meshheading:16339288-Female, pubmed-meshheading:16339288-Humans, pubmed-meshheading:16339288-Immunoglobulin G, pubmed-meshheading:16339288-Male, pubmed-meshheading:16339288-Middle Aged, pubmed-meshheading:16339288-Proportional Hazards Models, pubmed-meshheading:16339288-Prospective Studies, pubmed-meshheading:16339288-Receptors, Tumor Necrosis Factor, pubmed-meshheading:16339288-Time Factors, pubmed-meshheading:16339288-Treatment Outcome, pubmed-meshheading:16339288-Tumor Necrosis Factor-alpha
pubmed:year
2006
More...